DBD

DBD (DBD) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 47,000 VND, little changed on the session, giving a market capitalization of 4.8 trillion VND.

On valuation, DBD trades at a price-to-earnings ratio of 16.6 and a price-to-book of 2.7. That is a discount to the Health Care sector average P/E of 18.9. Return on equity of 16.0% points to solid profitability relative to the company's equity base, above the sector average of 11.5%. Trailing earnings per share stand at 3,082 VND.

Aveluro tracks 4 news items mentioning DBD, where recent coverage skews positive (75% of articles). The most recent catalyst was a dividend announcement event — "Bidiphar (DBD) Sets 20% Cash Dividend, Record Date Aug 28". Aveluro's composite model rates DBD 7.1/10 (Bullish), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Health Care sector include AGP, AMP and AMV.

Recent developments around DBD include 3 notable classified events. On Aug 16, 2026, a dividend announcement was reported: Bidiphar (DBD) will pay a 20% cash dividend for 2025, with the record date set for August 28, 2026, and payment on October 1, 2026. On May 13, 2026, a market event was reported: DBD partners with Citek to launch a comprehensive digital transformation project, upgrading to SAP S/4HANA Private Cloud and implementing CSV, IFRS, and BI systems. On Apr 17, 2026, a market event was reported: Bidiphar (DBD) will propose a private placement of 23.3 million shares to raise approximately VND 1,165 billion at a minimum price of VND 50,000 per share, targeting up to five professional investors.

The overall tone of recent coverage is positive, with 2 of 3 events carrying bullish sentiment.